The stock price of Phibro Animal Health Corp (NASDAQ: PAHC) has jumped by 14.75 compared to previous close of 19.39. Despite this, the company has seen a gain of 19.62% in its stock price over the last five trading days. zacks.com reported 2025-05-08 that PAHC’s third-quarter fiscal 2025 results reflect the strength of the Animal Health segment.
Is It Worth Investing in Phibro Animal Health Corp (NASDAQ: PAHC) Right Now?
Phibro Animal Health Corp (NASDAQ: PAHC) has a higher price-to-earnings ratio of 28.47x compared to its average ratio, The 36-month beta value for PAHC is at 0.63. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for PAHC is 20.19M, and currently, shorts hold a 4.32% of that float. The average trading volume for PAHC on May 09, 2025 was 274.00K shares.
PAHC’s Market Performance
PAHC stock saw an increase of 19.62% in the past week, with a monthly gain of 24.44% and a quarterly increase of -9.48%. The volatility ratio for the week is 6.16%, and the volatility levels for the last 30 days are 5.53% for Phibro Animal Health Corp (PAHC). The simple moving average for the past 20 days is 21.90% for PAHC’s stock, with a 3.59% simple moving average for the past 200 days.
Analysts’ Opinion of PAHC
Many brokerage firms have already submitted their reports for PAHC stocks, with JP Morgan repeating the rating for PAHC by listing it as a “Neutral.” The predicted price for PAHC in the upcoming period, according to JP Morgan is $22 based on the research report published on September 10, 2024 of the previous year 2024.
Exane BNP Paribas, on the other hand, stated in their research note that they expect to see PAHC reach a price target of $9. The rating they have provided for PAHC stocks is “Underperform” according to the report published on December 07th, 2023.
ROTH Capital gave a rating of “Buy” to PAHC, setting the target price at $18 in the report published on December 21st of the previous year.
PAHC Trading at 9.45% from the 50-Day Moving Average
After a stumble in the market that brought PAHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.20% of loss for the given period.
Volatility was left at 5.53%, however, over the last 30 days, the volatility rate increased by 6.16%, as shares surge +16.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading unchanged at present.
During the last 5 trading sessions, PAHC rose by +19.62%, which changed the moving average for the period of 200-days by +17.41% in comparison to the 20-day moving average, which settled at $18.25. In addition, Phibro Animal Health Corp saw 5.95% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PAHC starting from CORCORAN E THOMAS, who purchase 5,000 shares at the price of $22.10 back on Feb 24 ’25. After this action, CORCORAN E THOMAS now owns 30,000 shares of Phibro Animal Health Corp, valued at $110,500 using the latest closing price.
BFI Co., LLC, the 10% Owner of Phibro Animal Health Corp, proposed sale 247,769 shares at $25.77 during a trade that took place back on Feb 18 ’25, which means that BFI Co., LLC is holding shares at $6,385,007 based on the most recent closing price.
Stock Fundamentals for PAHC
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.32 for the gross margin
The net margin for Phibro Animal Health Corp stands at 0.02. The total capital return value is set at 0.07. Equity return is now at value 11.86, with 2.77 for asset returns.
Based on Phibro Animal Health Corp (PAHC), the company’s capital structure generated 0.76 points at debt to capital in total, while cash flow to debt ratio is standing at 0.07. The debt to equity ratio resting at 3.2. The interest coverage ratio of the stock is 2.67.
Currently, EBITDA for the company is 84.61 million with net debt to EBITDA at 6.72. When we switch over and look at the enterprise to sales, we see a ratio of 1.47. The receivables turnover for the company is 5.77for trailing twelve months and the total asset turnover is 0.86. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.91.
Conclusion
In conclusion, Phibro Animal Health Corp (PAHC) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
